WO2024240728 - INHIBITOR
National phase entry:
Publication Number
WO/2024/240728
Publication Date
28.11.2024
International Application No.
PCT/EP2024/063879
International Filing Date
21.05.2024
Title **
[English]
INHIBITOR
[French]
PROCÉDÉ ET INTERMÉDIAIRES POUR LA PRÉPARATION D'UN INHIBITEUR DE P2X
Applicants **
CHIESI FARMACEUTICI S.P.A.
Via Palermo 26/A
43122 Parma, IT
Inventors
BOCCHI, Monica
c/o Chiesi Farmaceutici S.p.A.
Via Palermo 26/A
43122 Parma, IT
CARDINALI, Luca
c/o Chiesi Farmaceutici S.p.A.
Via Palermo 26/A
43122 Parma, IT
PIVETTI, Fausto
c/o Chiesi Farmaceutici S.p.A.
Via Palermo 26/A
43122 Parma, IT
MARI, Massimiliano
c/o Chiesi Farmaceutici S.p.A.
Via Palermo 26/A
43122 Parma, IT
RONCHI, Paolo
c/o Chiesi Farmaceutici S.p.A.
Via Palermo 26/A
43122 Parma, IT
LATHBURY, David C.
c/o Chiesi Farmaceutici S.p.A.
Via Palermo 26/A
43122 Parma, IT
MARIANI, Edoardo
c/o Chiesi Farmaceutici S.p.A.
Via Palermo 26/A
43122 Parma, IT
Priority Data
23174500.1
22.05.2023
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1046 | |
| EPO | Filing, Examination | 4575 | |
| Japan | Filing | 587 | |
| South Korea | Filing | 574 | |
| USA | Filing, Examination | 4510 |
Total: 11292 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
inhibitor is suitable for medical use in pharmaceutical applications.[French]
synthétisé est approprié pour une utilisation médicale dans des applications pharmaceutiques.